Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. While many investors like to look for momen ...

Tenet Healthcare (THC) closed at $164.62 in the latest trading session, marking a +1.36% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.13% for the day. On the other hand, the Dow registered a gain of 0.55%, and the technology-centric Nasdaq decreased by 0.52%. The hospital operator's shares have seen an increase of 3.67% over the last month, surpassing the Medical sector's gain of 3.34% and aligning with the S&P 500. The investment community will be closely monitoring ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Let's take a look at what these Wall Street heavyweights have to say about Tenet Healthcare (THC) before we discuss the reliability of brokerage recommendations and how to use them to your advantage. Tenet currently has an average brokerage recommendatio ...

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks and waiting long for them to recover. They believe instead that one could make far more money in lesser time by "buying high and selling higher." Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth p ...

JHVEPhoto Health Care stocks have put on a show in recent months. While not in the limelight, the sector mixed with high-growth names and defensive equities has notched all-time highs, driven in large part by massive gains in pharma giant Eli Lilly (LLY). But smaller stocks within the broad sector have also been on the rise as the space has undergone changes post-COVID. I am downgrading Tenet Healthcare (NYSE:THC) from a buy to a hold, however. The No. 6-ranked out of 1034 members of the Health Care sector ...

Tenet Healthcare Corporation (THC) shares have returned 24.6% in the past three months, outperforming both the hospital industry and the S&P 500 Index. Over this timeframe, the industry and the S&P 500 Indexhave gained 20.8% and 6.4%, respectively. Currently priced at $163.87, the stock is just 1% below its 52-week high. This proximity underscores investor confidence and market optimism about this hospital company's prospects. Moreover, the stock is trading above its 50-day and 200-day moving averages, sign ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. It also includes access to the Zacks Style Scores. What are ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Tenet Healthcare (THC) . Tenet currently has an average brokerage recommendation (ABR) of 1.17 ...

Core Viewpoint - Tenet Healthcare (THC) has shown strong stock performance recently, with a +7.2% return over the past month, outperforming the S&P 500 composite's +0.3% and the Zacks Medical - Hospital industry's +18.7% [1] Earnings Estimates Revisions - Tenet is expected to post earnings of $2.33 per share for the current quarter, reflecting a year-over-year increase of +61.8%, with a consensus estimate change of +44.2% over the last 30 days [4] - The consensus earnings estimate for the current fiscal year is $10.70, indicating a year-over-year change of +53.3%, with a +20.6% change in estimates over the last 30 days [4] - For the next fiscal year, the consensus earnings estimate is $10.96, showing a +2.4% change from the previous year, with a +24.4% change in estimates over the past month [5] Stock Rating and Valuation - Tenet has received a Zacks Rank 1 (Strong Buy), indicating a strong potential for near-term price performance based on earnings estimate revisions [6] - The Zacks Value Style Score grades Tenet as A, suggesting it is trading at a discount compared to its peers [14] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $5.05 billion, indicating a year-over-year change of -0.4%, while estimates for the current and next fiscal years are $20.84 billion (+1.4%) and $21.64 billion (+3.8%), respectively [8] Last Reported Results - In the last reported quarter, Tenet generated revenues of $5.1 billion, a year-over-year increase of +0.4%, and an EPS of $2.31 compared to $1.44 a year ago [9] - The reported revenues exceeded the Zacks Consensus Estimate of $4.98 billion by +2.49%, and the EPS surprise was +22.22% [10]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell even higher, with the expectation that established trends will continue [1] Company Overview: Tenet Healthcare (THC) - Tenet Healthcare currently holds a Momentum Style Score of B and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [3][4] - Over the past week, THC shares increased by 5.86%, while the Zacks Medical - Hospital industry remained flat [6] - In a longer timeframe, THC's monthly price change is 17.76%, outperforming the industry's 15.59% [6] - Over the past quarter, THC shares rose by 20.29%, and over the last year, they increased by 117.79%, compared to the S&P 500's gains of 4.75% and 26.5%, respectively [7] Trading Volume - THC's average 20-day trading volume is 1,485,728 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, 8 earnings estimates for THC have been revised upwards, increasing the consensus estimate from $8.74 to $10.70 [10] - For the next fiscal year, 9 estimates have also moved upwards, with no downward revisions [10]